Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia

被引:16
|
作者
Grecso, Nora [1 ]
Zadori, Anita [1 ]
Szecsi, Ilona [1 ]
Barath, Akos [1 ]
Galla, Zsolt [1 ]
Bereczki, Csaba [1 ]
Monostori, Peter [1 ]
机构
[1] Univ Szeged, Dept Pediat, Metab & Newborn Screening Lab, Szeged, Hungary
来源
PLOS ONE | 2020年 / 15卷 / 05期
关键词
MASS-SPECTROMETRY; FILTER-PAPER; WHOLE-BLOOD; 17-ALPHA-HYDROXYPROGESTERONE; HORMONE; RADIOIMMUNOASSAY; SAMPLES;
D O I
10.1371/journal.pone.0233724
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Congenital adrenal hyperplasia (CAH) is a severe inherited disorder of cortisol biosynthesis that is potentially lethal or can seriously affect quality of life. For the first time, we aimed to assess the stability of 21-deoxycortisol (21Deox), 11-deoxycortisol (11Deox), 4-androstenedione (4AD), 17-hydroxprogesterone (170HP) and cortisol (Cort), diagnostic for CAH, in dried blood spots (DBSs) during a 1 year storage at different temperatures. Spiked DBS samples were stored at room temperature, 4 degrees C, -20 degrees C or -70 degrees C, respectively and analyzed in triplicates using liquid chromatography tandem mass spectrometry at Weeks 0, 1, 2, 3 and 4, Month 6 and Year 1. Analyte levels within 15% vs the baseline were considered stable. Our observations show that 21Deox, 4AD and 170HP were not significantly changed for 1 year even at room temperature at either analyte levels. In contrast, Cort required storage at 4 degrees C, -20 degrees C or -70 degrees C for long-term stability, being significantly decreased at room temperature from Month 6 (p<0.01) in both the 30(60) nM and the 90(180) nM samples. 11Deox was significantly decreased at room temperature at Year 1 (p<0.01) and only in the 30(60) nM samples. Thus, all biomarkers were stable for up to 1 year at 4 degrees C, -20 degrees C or -70 degrees C and at least for 4 weeks at room temperature. These findings have implications for analyses of stored DBS samples in 2nd-tier assays in newborn screening and for retrospective CAH studies.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia
    King, JL
    Naber, JM
    Hopkin, RJ
    Repaske, DR
    Bailey, L
    Leslie, ND
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2001, 155 (09): : 1038 - 1042
  • [32] How reliable is newborn screening for congenital adrenal hyperplasia?
    Kenneth A Pass
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 (2): : 74 - 75
  • [33] Diagnosis of congenital adrenal hyperplasia by ultrasound in the newborn.
    Brock, JW
    Hernanz-Schulman, M
    Russell, W
    [J]. PEDIATRICS, 1998, 102 (03) : 830 - 831
  • [34] Expansion of a Second-Tier Newborn Screening Panel for Congenital Adrenal Hyperplasia to Include 21-Deoxycortisol and 11-Deoxycortisol Measurements From Dried Blood Spots
    Greene, Dina N.
    Schwarz, Elisabeth
    Pasquali, Marzia
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (03) : 463 - 464
  • [35] Usefulness of dried blood spots in the diagnosis of congenital CMV
    F Piersigilli
    C Auriti
    [J]. Journal of Perinatology, 2013, 33 : 495 - 496
  • [36] Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening
    Monostori, Peter
    Szabo, Pal
    Marginean, Otilia
    Bereczki, Csaba
    Karg, Eszter
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2015, 84 (05): : 311 - 318
  • [37] Usefulness of dried blood spots in the diagnosis of congenital CMV
    Piersigilli, F.
    Auriti, C.
    [J]. JOURNAL OF PERINATOLOGY, 2013, 33 (06) : 495 - 496
  • [38] Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots
    Gelb, Michael H.
    Lukacs, Zoltan
    Ranieri, Enzo
    Schielen, Peter C. J. I.
    [J]. INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2019, 5 (01)
  • [39] Contamination of dried blood spots - an underestimated risk in newborn screening
    Winter, Theresa
    Lange, Anja
    Hannemann, Anke
    Nauck, Matthias
    Mueller, Cornelia
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (02) : 278 - 284
  • [40] Secondary use of dried blood spots from newborn screening
    Leung, Christy W. M.
    Cheng, N. S.
    Leung, T. F.
    [J]. HONG KONG MEDICAL JOURNAL, 2024, 30 (04) : 338 - 338